Topper David Joseph 4
4 · Arcutis Biotherapeutics, Inc. · Filed Apr 11, 2024
Insider Transaction Report
Form 4
Topper David Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-04-10+110,000→ 110,000 total - Award
Stock Option (right to buy)
2024-04-10+310,000→ 310,000 totalExercise: $12.34Exp: 2034-04-10→ Common Stock (310,000 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of April 10, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option will vest and become exercisable as to 25% of the shares on the first annual anniversary of the grant date of April 10, 2024, and the remaining options will vest at 2.0833%, on each monthly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date.